This kind of behaviour will slowly push patient associations and labs to seek P2P solutions. A platform that connects patients, scientists and independent labs

This kind of behaviour will slowly push patient associations and labs to seek P2P solutions. A platform that connects patients, scientists and independent labs in countries like Japan or Switzerland would cut all the middle-men (pharma, FDA, etc) and would prevent these abuses.